David Roth, Chief Medical Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 6,287 shares at $4.95 ($31K) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Scheduled sale ($31k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SYRS | SELL | 2024-04-02 | $747 | — | Filing → |
| SYRS | SELL | 2023-12-08 | $25K | — | Filing → |
| SYRS | SELL | 2023-08-02 | $29K | — | Filing → |